Although the levonorgestrel intrauterine system (LNG IUS) has been shown to be an effective treatment for heavy menstrual bleeding (HMB), previous clinical trials included rigorous criteria focused primarily on measuring the severity of bleeding.
During the past few months, there has been a pleth-ora of articles published with important clinical implications, and I have found it difficult to pick just one to review.
LAP2 was a phase 3 clinical trial to assess the non-inferiority of laparoscopy compared with laparotomy for recurrence of uterine cancer after surgical staging.
When One Antihypertensive Med is Not Enough: Which Combination?; Vitamin D for Osteoarthritis: NOT; Early Identification of COPD Exacerbations; CKD: Consistency of GFR and Albuminuria as Risk Predictors; Changing Outcomes for Patients with Chronic Hepatitis C; Is Fructose a Primary Culprit in Obesity?
